EN
抗体药类似物
Research Grade Siltuximab
All
TD-HY328016_1.jpg
TD-HY328016_2.jpg
TD-HY328016_3.jpg
  • CatalogTD-HY328016
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsCLLB8,CNTO328,CAS:541502-14-1
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Siltuximab


Catalog No. TD-HY328016
Species reactivity Human
Applications Research Grade Biosimilar
Host species Chimeric
Isotype IgG1-kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target Hybridoma growth factor, BSF-2, IFN-beta-2, CDF, IL6, Interleukin-6, IL-6, B-cell stimulatory factor 2, Interferon beta-2, IFNB2, CTL differentiation factor
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession P05231
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names CLLB8,CNTO328,CAS:541502-14-1
Background Siltuximab is an anti-IL-6 (interleukin-6) monoclonal antibody, and shows antitumor activity. Siltuximab can be used in Multicentric Castleman's Disease (MCD) and COVID-19 research.
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-HY328016_1.jpg
SEC-HPLC
 
SEC-HPLC detection for Research Grade Siltuximab.
TD-HY328016_2.jpg
Bioactivity
 
Detects Human IL6 in indirect ELISAs.
TD-HY328016_3.jpg
SDS-PAGE
 
SDS-PAGE for Research Grade Siltuximab.